about
The origin of GPCRs: identification of mammalian like Rhodopsin, Adhesion, Glutamate and Frizzled GPCRs in fungiHow to manage aspergillosis in non-neutropenic intensive care unit patientsClinical manifestations and outcomes of pulmonary aspergillosis: experience from PakistanFatal clinical course of probable invasive pulmonary aspergillosis with influenza B infection in an immunocompetent patient.Invasive pulmonary aspergillosis in a patient presenting with idiopathic systemic capillary leak syndrome.Detection of galactomannan in bronchoalveolar lavage of the intensive care unit patients at risk for invasive aspergillosisAspergillus colonization in patients with chronic obstructive pulmonary diseaseFive-years surveillance of invasive aspergillosis in a university hospital.Cryptic and rare Aspergillus species in Brazil: prevalence in clinical samples and in vitro susceptibility to triazoles.Aspergillosis in Intensive Care Unit (ICU) patients: epidemiology and economic outcomes.Evaluation of MycAssay™ Aspergillus for diagnosis of invasive pulmonary aspergillosis in patients without hematological cancer.Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections.How to treat fungal infections in ICU patients.Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patientsDiagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay.Invasive pulmonary aspergillosis accompanied by soft tissue lesions during treatment of a patient with hyperthyroidism: a case report.Pulmonary aspergillosis: clinical presentation, diagnostic tests, management and complications.A novel extraction method combining plasma with a whole-blood fraction shows excellent sensitivity and reproducibility for patients at high risk for invasive aspergillosis.Pharmacokinetics of amphotericin B colloidal dispersion in critically ill patients with cholestatic liver diseaseRapid detection and identification of Aspergillus from lower respiratory tract specimens by use of a combined probe-high-resolution melting analysis.Is Bulpa criteria suitable for the diagnosis of probable invasive pulmonary Aspergillosis in critically ill patients with chronic obstructive pulmonary disease? A comparative study with EORTC/ MSG and ICU criteria.Invasive pulmonary mucormycosis: rare presentation with pulmonary eosinophiliaClinical risk factors and bronchoscopic features of invasive aspergillosis in intensive care unit patientsRole of galactomannan determinations in bronchoalveolar lavage fluid samples from critically ill patients with chronic obstructive pulmonary disease for the diagnosis of invasive pulmonary aspergillosis: a prospective studyMulticenter comparison of serum and whole-blood specimens for detection of Aspergillus DNA in high-risk hematological patients.Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study.Fungal infections in intensive care unit: challenges in diagnosis and managementRevised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/Common Genetic Polymorphisms within NFκB-Related Genes and the Risk of Developing Invasive AspergillosisManagement of invasive aspergillosis in patients with COPD: rational use of voriconazole.Invasive fungal infections in patients with cancer in the Intensive Care Unit.Pulmonary epithelial lining fluid concentrations after use of systemic amphotericin B lipid formulations.Invasive mold infections: recent advances in management approaches.Corticosteroids block autophagy protein recruitment in Aspergillus fumigatus phagosomes via targeting dectin-1/Syk kinase signaling.Invasive fungal tracheobronchitis in mechanically ventilated critically ill patients: underlying conditions, diagnosis, and outcomes.Invasive fungal infections in the ICU.MiR-344b-1-3p targets TLR2 and negatively regulates TLR2 signaling pathway.Challenges in microbiological diagnosis of invasive Aspergillus infections.Current aspects of invasive candidiasis and aspergillosis in adult intensive care patients.Epidemiology and antifungal resistance in invasive Aspergillosis according to primary disease: review of the literature.
P2860
Q21134911-A013293F-1DAE-407B-BC47-6E44B6DCA083Q26999448-C31FA972-9F51-42B2-902E-2C6AF2A59BD3Q28354102-4752D179-AA86-405D-8F76-C2F338A15809Q30367762-82E04D30-2914-4A74-B0E0-A8D1DB638197Q33691672-78DF992C-62FD-42DC-903B-641FDAA83BF9Q33851382-F888E26F-223F-46DB-BB5E-8A34251DDC15Q33851401-AC79492F-A788-4EFC-86E4-91E80D9C8FDBQ33926071-6D3A764B-1516-4B1B-8951-3419ED4F1BB3Q34298083-E55C15CB-E6B7-4DA7-AA04-FD84F952123DQ34559978-DE5574D2-EED7-4F3D-8C0A-8FFB665964B2Q34688953-21D08C34-4ACF-451E-B9C6-A21135E06A0BQ34900399-58E9E45D-FABF-42CF-AB61-69578103D9A4Q35568846-47369696-2C8F-4D3D-AE49-5E76DB1ECE84Q35575320-41EF959E-FBEB-43F0-B81D-302FC0FC5449Q35599066-DCF49A7D-0303-4B81-BAF5-B030066BA0EEQ35756322-05F6A603-AE7B-47F2-9879-47F453533790Q35889014-1BFE7428-67FB-4DFA-AE3F-55203CECFCAEQ36171444-F6D15302-C116-4911-926F-6539B0174906Q36276845-8889C8FB-DB5C-4FD3-985C-61F8C5CF52C1Q36276996-8AA9A66A-0967-46C4-9DB4-1A2371B5A616Q36307784-86EE7A61-9864-4CD4-91BE-8AA5EC23665AQ36358482-256B67A9-36A3-4B68-AAD3-4CB7E3E4879CQ36478542-65B1381F-01A0-4C0B-8E39-018DD83A9892Q36633947-068E7455-0C32-4DA3-B00C-35ECA020D33FQ36826645-99FD7863-3EAC-4533-81D8-30D679C65BD9Q36886708-52C2345B-01C1-4156-A851-97E48A991B4FQ37058527-CA629B5D-E54A-4643-BF09-F25EDB276945Q37164067-CBA50258-81AB-4D98-81ED-AF85A9A7495BQ37169890-3CCFD2B2-8DD7-42EF-8B0C-09124DE8E3F8Q37294689-5135454F-4F4C-4B04-AA5D-627EB0C8B418Q37373771-72632AEE-0D6C-48F1-8A18-036DC9955CE9Q37409856-DB7EED49-2560-48DB-AAC4-5A5FFD25B1E9Q37428946-F06E6B03-C2D8-45DE-A33E-CF74070A63ECQ37442775-B3D0FBDF-810E-426D-B072-EF82A039560FQ37583916-71291E2B-5CAC-4E5C-AB91-AA63D0C4B0D9Q37643057-B4929107-0DE0-4F5F-8D98-85DEBE6AF691Q37652831-9D392E3D-835D-42E6-BB99-CA47A0175A51Q37659157-ECF4EA41-F65B-466F-B350-77AADFD0BE95Q37759256-BED622ED-57BD-41BB-89D5-449A93B5004DQ37864427-1B30B479-B713-4DDE-9482-098E1B19C77C
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Invasive aspergillosis in the intensive care unit
@ast
Invasive aspergillosis in the intensive care unit
@en
Invasive aspergillosis in the intensive care unit
@nl
type
label
Invasive aspergillosis in the intensive care unit
@ast
Invasive aspergillosis in the intensive care unit
@en
Invasive aspergillosis in the intensive care unit
@nl
prefLabel
Invasive aspergillosis in the intensive care unit
@ast
Invasive aspergillosis in the intensive care unit
@en
Invasive aspergillosis in the intensive care unit
@nl
P2093
P2860
P3181
P356
P1476
Invasive aspergillosis in the intensive care unit
@en
P2093
Johan Maertens
Katrien Lagrou
Wouter Meersseman
P2860
P304
P3181
P356
10.1086/518852
P407
P577
2007-07-15T00:00:00Z